Logo Logo
Switch Language to German

Buhrmann, Constanze; Shayan, Parviz; Popper, Bastian; Goel, Ajay and Shakibaei, Mehdi (2016): Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells. In: Nutrients, Vol. 8, No. 3 [PDF, 2MB]

[thumbnail of 10.3390_nu8030145.pdf]
Download (2MB)


Sirt1 is a NAD(+)-dependent protein-modifying enzyme involved in regulating gene expression, DNA damage repair, metabolism and survival, as well as acts as an important subcellular target of resveratrol. The complex mechanisms underlying Sirt1 signaling during carcinogenesis remain controversial, as it can serve both as a tumor promoter and suppressor. Whether resveratrol-mediated chemopreventive effects are mediated via Sirt1 in CRC growth and metastasis remains unclear;which was the subject of this study. We found that resveratrol suppressed proliferation and invasion of two different human CRC cells in a dose-dependent manner, and interestingly, this was accompanied with a significant decrease in Ki-67 expression. By transient transfection of CRC cells with Sirt1-ASO, we demonstrated that the anti-tumor effects of resveratrol on cells was abolished, suggesting the essential role of this enzyme in the resveratrol signaling pathway. Moreover, resveratrol downregulated nuclear localization of NF-kappa B, NF-kappa B phosphorylation and its acetylation, causing attenuation of NF-kappa B-regulated gene products (MMP-9, CXCR4) involved in tumor-invasion and metastasis. Finally, Sirt1 was found to interact directly with NF-kappa B, and resveratrol did not suppress Sirt1-ASO-induced NF-kappa B phosphorylation, acetylation and NF-kappa B-regulated gene products. Overall, our results demonstrate that resveratrol can suppress tumorigenesis, at least in part by targeting Sirt1 and suppression of NF-kappa B activation.

Actions (login required)

View Item View Item